Fidelis Capital Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $320K | Buy |
4,070
+469
| +13% | +$36.9K | 0.03% | 335 |
|
|
2025
Q1 | $274K | Sell |
3,601
-362
| -9% | -$27.5K | 0.03% | 336 |
|
|
2024
Q4 | $283K | Sell |
3,963
-580
| -13% | -$41.4K | 0.03% | 346 |
|
|
2024
Q3 | $321K | Sell |
4,543
-1,028
| -18% | -$72.6K | 0.04% | 306 |
|
|
2024
Q2 | $340K | Buy |
5,571
+507
| +10% | +$31K | 0.05% | 262 |
|
|
2024
Q1 | $484K | Buy |
5,064
+690
| +16% | +$65.9K | 0.07% | 214 |
|
|
2023
Q4 | $334K | Buy |
4,374
+586
| +15% | +$44.7K | 0.07% | 230 |
|
|
2023
Q3 | $262K | Sell |
3,788
-677
| -15% | -$46.9K | 0.09% | 217 |
|
|
2023
Q2 | $421K | Buy |
4,465
+233
| +6% | +$22K | 0.15% | 151 |
|
|
2023
Q1 | $376K | Buy |
+4,232
| New | +$376K | 0.16% | 147 |
|